This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Rutgers Business School To Host Its First Biopharmaceutical Case Competition

Julie Oka, a Rutgers MBA student who serves with Parker as co-president of the school's pharmaceutical club, said the corporate sponsors backing the event at Rutgers helped to attract teams from some of the country's leading business schools. "These competitions are recruiting tools for the companies. People get jobs out of these competitions,'' she said. 

Mahmud Hassan, a professor in the pharmaceutical management program, said the competitions serve multiple purposes, including marketing Rutgers to prospective students who want to concentrate their MBA studies in pharmaceutical management. 

"It's a good thing for the companies to see talent in one place,'' Hassan said, "but for us, it's also a way of letting the top-ranked business schools know we're a player in this industry, that our students are also top-ranked.''

Teams from the following schools will participate: Boston University, School of Management, Columbia Business School, Duke University's Fuqua School of Management, George Washington University's School of Business and Georgetown University's McDonough School of Business.

There will also be teams from New York University's Stern School of Business, Pennsylvania State University's Smeal College of Business, University of Connecticut's School of Business, University of Rochester's Simon Graduate School of Business and Wake Forest University's School of Business.  

The event is being sponsored by some of the world's largest pharmaceutical companies: Bayer, Bristol-Myers Squibb, Eisai, Johnson & Johnson, Merck, Novartis and Campbell-Alliance, a leading consultant to the biopharmaceutical and medical technology industries.

Parker said getting seven companies to sign on as sponsors was a huge factor in attracting so many teams and teams from some of the country's top-ranked business schools.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs